Cinnamomum burmannii
StarCinnamomum burmannii
Synonyms: Cinnamomum dulcis
Western Herbalism Properties
Traditional Uses
In its native South-East Asia the bark of Cinnamomum burmannii is a long-standing culinary-medicinal aromatic. In Indonesia it is incorporated into traditional jamu herbal preparations, taken as a warming tonic and to settle the stomach, ease flatulence and check diarrhoea, uses consistent with the carminative and astringent reputation of cassia bark (Katzer, 2012; WebMD, n.d.).
Botanical Description
Cinnamomum burmannii, known as Indonesian cinnamon, Padang cassia, Batavia cassia or korintje, is an evergreen tree of the family Lauraceae native to South-East Asia and cultivated above all in the Kerinci highlands of West Sumatra, Indonesia. It reaches about 7 to 15 metres in height, with smooth grey-brown bark on the trunk and aromatic inner bark that is the source of the commercial spice. The leaves are leathery, opposite to sub-opposite, elliptic to lance-shaped, glossy dark green above and paler beneath, with three prominent longitudinal veins and a spicy fragrance when crushed; young foliage is often flushed red. Small yellowish to greenish flowers are borne in axillary and terminal panicles, followed by small ovoid dark berries seated in a shallow cup. The dried inner bark is harvested in curled quills and contains an essential oil rich in cinnamaldehyde, together with notably high levels of coumarin compared with Ceylon cinnamon.
Active Constituents
trans-Cinnamaldehyde
Phenylpropanoid aldehydeConcentration: Bark essential oil 60-90%; leaf oil ~50-60%
The dominant aromatic constituent of the bark oil, responsible for the characteristic cinnamon odour. It shows antimicrobial, antifungal, anti-inflammatory, antioxidant and insulin-sensitising activity in laboratory studies, and is the principal marker used to authenticate cassia oils.
Coumarin
BenzopyroneConcentration: Bark ~2,100-4,400 mg/kg (much higher than Ceylon cinnamon)
A simple benzopyrone present in far higher amounts than in true (Ceylon) cinnamon. It is the main safety concern of cassia because chronic high intake is hepatotoxic in susceptible individuals; European authorities set a tolerable daily intake of 0.1 mg/kg body weight based on coumarin exposure from cassia.
Eugenol
PhenylpropanoidConcentration: Leaf oil up to ~18%; minor in bark
An aromatic phenol concentrated in the leaf oil that contributes analgesic, antiseptic and antioxidant properties. It scavenges free radicals and has local anaesthetic-type activity.
Cinnamic acid
Phenylpropanoid acidConcentration: Minor bark constituent
An oxidation product of cinnamaldehyde with reported antioxidant and antimicrobial activity that also contributes to the aroma profile.
Cinnamyl alcohol / cinnamyl acetate
Phenylpropanoid alcohol/esterConcentration: Minor essential-oil components
Aroma-active minor terpenoid-related components of the essential oil that contribute to the sweet, balsamic note of the bark.
Proanthocyanidins / condensed tannins
Polyphenol (oligomeric flavan-3-ols)Concentration: Present in aqueous bark extract
Water-soluble polyphenols of the bark that account for much of the antioxidant capacity of cinnamon tea and are the fraction most studied for possible effects on glucose metabolism and insulin signalling.
⚠ Drug Interactions
Anticoagulant / antiplatelet drugs (e.g. warfarin)
Cassia bark contains high levels of coumarin; although simple coumarin is not itself a potent anticoagulant, concentrated supplements taken with vitamin-K-antagonist anticoagulants create a theoretical additive concern, and the hepatic load may alter drug metabolism.
Clinical note: Culinary amounts are not a concern; patients on warfarin using high-dose cassia supplements should have INR monitored.
Antidiabetic medications (metformin, sulfonylureas, insulin)
Cassia polyphenols and cinnamaldehyde may improve insulin sensitivity, so concentrated extracts taken with glucose-lowering drugs could in principle add to their effect, though controlled trials of C. burmannii have shown inconsistent glycaemic effects.
Clinical note: Monitor blood glucose if high-dose cinnamon supplements are combined with diabetes medication.
Hepatotoxic drugs (e.g. acetaminophen/paracetamol, methotrexate)
Coumarin from cassia is metabolised in the liver and is hepatotoxic in susceptible people; combining chronic high-dose cassia with other hepatotoxic agents could increase liver stress.
Clinical note: Avoid sustained high-dose cassia supplements in patients with liver disease or on hepatotoxic medication.
Preparation Methods
Ground spice / infusion (tea)
Parts: bark
Dried inner bark is ground and used as a culinary spice or steeped (about 1-2 g per cup) as a warming infusion. Because C. burmannii (korintje/Padang cassia) is high in coumarin, regular high daily intake of the powder should be avoided; occasional culinary use is considered safe.
Essential oil (steam distillation)
Parts: bark, leaf
Steam distillation yields a cinnamaldehyde-rich bark oil (or eugenol-rich leaf oil) used in flavouring and aromatherapy. Cinnamaldehyde-rich oils are potent skin and mucous-membrane irritants and sensitisers; they must be heavily diluted for topical use and never taken undiluted internally.
Aqueous / hydroalcoholic extract
Parts: bark
Water or hydroalcoholic extraction concentrates polyphenols and lowers the fat-soluble coumarin fraction relative to the whole bark; such extracts are the form used in most glucose and antioxidant studies. Standardised supplements should note their coumarin content.
Clinical Studies
Effect of Aqueous Cinnamon Extract on the Postprandial Glycemia Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
A crossover randomized trial in patients with type 2 diabetes tested an aqueous extract of Cinnamomum burmannii. The extract did not significantly change postprandial glycaemia (incremental area under the curve, peak glucose) compared with control, although it demonstrated appreciable antioxidant capacity.
Historical Texts
Rumphius, Herbarium Amboinense
Compiled late 17th c., published 1741-1750European colonial spice pharmacopoeias / materia medica of the East Indies trade
18th-19th centuryReferences
- Al-Dhubiab BE. Pharmaceutical applications and phytochemical profile of Cinnamomum burmannii . Pharmacognosy Reviews (Asian Pacific / Pharmacogn Rev) (2012) [DOI]
- Woehrlin F, Fry H, Abraham K, Preiss-Weigert A. Quantification of flavoring constituents in cinnamon: high variation of coumarin in cassia bark from the German retail market and in authentic samples from Indonesia . Journal of Agricultural and Food Chemistry (2010) [DOI]
- Rachid AP, Moncada M, de Mesquita MF, Brito J, Bernardo MA. Effect of Aqueous Cinnamon Extract on the Postprandial Glycemia Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial . Nutrients (2022) [DOI]
This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.
📝 Notes
Public notes from the community and your own private notes on Cinnamomum burmannii.
No notes yet.